Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Premier Anti-Aging CoTSE:4934 -0.33%67 EBITDA Margin % is 6.00% as of Jan. 2026, which is 35% above its 10-year median of 4.45. GuruFocus rates TSE:4934 with a GF Score™ of 67/100 and a GF Value™ of 円578.68 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,961 Consumer Packaged Goods companies, Premier Anti-Aging Co ranks worse than 69.4% on this metric.
Premier Anti-Aging Co (TSE:4934) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Premier Anti-Aging Co EBITDA Margin % Related Terms
Premier Anti-Aging Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Premier Anti-Aging Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4934 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Premier Anti-Aging Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Premier Anti-Aging Co EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Premier Anti-Aging Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Premier Anti-Aging Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Premier Anti-Aging Co (TSE:4934) has a EBITDA Margin % of 6.00% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Premier Anti-Aging Co and its competitors. This is 35% above median its historical median of 4.45. According to the industry distribution chart, Premier Anti-Aging Co ranks #1361 out of 1961 companies in the Consumer Packaged Goods industry, placing it in the top 69.4%.
Is Premier Anti-Aging Co's EBITDA Margin % too high?
Premier Anti-Aging Co's current EBITDA Margin % of 6.00% is 35% above median its 10-year median of 4.45. The Consumer Packaged Goods industry median EBITDA Margin % is 9.07. Premier Anti-Aging Co's value of 6.00% is 33.8% below this industry median. Based on the distribution chart, Premier Anti-Aging Co ranks #1361 out of 1961 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Premier Anti-Aging Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Premier Anti-Aging Co's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Premier Anti-Aging Co ranks #1361 out of 1961 companies for EBITDA Margin %. This places Premier Anti-Aging Co in the lower half of its industry. The industry median EBITDA Margin % is 9.07. Premier Anti-Aging Co's value of 6.00% is 33.8% below this benchmark. While the company's 10-year median is 4.45 vs. the industry median of 9.07, Premier Anti-Aging Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.07, based on 1,961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Premier Anti-Aging Co's current EBITDA Margin % of 6.00% is 33.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Premier Anti-Aging Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Premier Anti-Aging Co's current EBITDA Margin % is 6.00%, which is 35% above median its own 10-year median of 4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Anti-Aging Co stock overvalued right now?
Based on GuruFocus' analysis, Premier Anti-Aging Co (TSE:4934) is currently considered Fairly Valued. The stock's GF Value™ is 円578.68, compared to a current price of 円597.00 — trading 3.2% above its estimated fair value. The current EBITDA Margin % is 6.00%, which is 35% above median its 10-year median of 4.45 and 33.8% below the Consumer Packaged Goods industry median of 9.07. Premier Anti-Aging Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Premier Anti-Aging Co (TSE:4934), the current EBITDA Margin % is 6.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Premier Anti-Aging Co (TSE:4934) Overvalued in 2026?
Based on GuruFocus' analysis, Premier Anti-Aging Co stock appears to be overvalued.
The current stock price of 円597.00 is trading 3.2% above its estimated GF Value™ of 円578.68.
GuruFocus considers Premier Anti-Aging Co to be Fairly Valued.
Key valuation signals for TSE:4934:
EBITDA Margin %: 6.00% (35% above median its 10-year median of 4.45)
GF Value™: 円578.68 vs. price of 円597.00 (3.2% above fair value)
Industry Position: 33.8% below the Consumer Packaged Goods median (#1361 of 1961)
No single metric tells the full story. See the TSE:4934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Premier Anti-Aging Co Ltd operates in the anti-aging and recovery business fields. The anti-aging business mainly involves the manufacturing and sales of skincare, haircare, and inner care products, and it operates brands such as DUO, CANADEL, and CREAENCE. The recovery business mainly involves the manufacturing and sales of recovery wear, etc., through its subsidiary. The majority of revenue is derived from the Anti-aging Business.
67GF Score
Get the complete analysis for TSE:4934
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4934 has been successfully added to your 
